Purchase Order 75N93024P01048

Award Date 8/26/24
Potential Completion Date 6/30/25
Potential Value $24K
Ultimate Awardee
Not listed
PSC Category
6810 - Chemicals
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Pleasanton, CA 94588, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to 10X Genomics, Inc., a small business manufacturer of life sciences products and services. The $14,577.00 contract is for the delivery of Chromium Next GEM kits and reagents to support NIAID's biomedical research and development activities. This award is part of a larger indefinite delivery contract between...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a civilian agency, to 10X Genomics, Inc., a small business manufacturer, with a ceiling value of $23,849.00 and an ultimate completion date of August 20, 2024. The contract provides for the delivery of 10X Genomics Chromium kits, which are products and services for single-cell and spatial analysis applications to enable high-throughput interrogation of biological...
This is a firm fixed price purchase order awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to 10X Genomics, Inc. for the delivery of Chromium kits and accessories. The contract is a small business set-aside with a potential value of $110,402.80. The products include various 10X Genomics kits for single-cell RNA sequencing, single-cell ATAC sequencing, single-cell multi-omics, and spatial...
This is a firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,585.50 contract is for the provision of CHROMIUM GEM-X SINGLE CELL KIT, which are specialized products used in single-cell analysis applications. The contract has a period of performance through September 30, 2024 and is set aside for small businesses. 10X Genomics is a...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH) under the Department of Health and Human Services, to 10X Genomics, Inc. for the procurement of Chromium GEM-X Single Cell 3' Chip Kits and Chromium GEM-X Single Cell 3' Kits. The contract has a total ceiling value of $23,773.00 and a completion date of October 31, 2024. It was set aside for small businesses and was competed...
This is a firm-fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to 10X Genomics, Inc., a small business manufacturer of genomic analysis products and services. The $76,328.50 contract is for the procurement of various Chromium kits, including the Chromium GEM-X Single Cell 5' Kit v3, Chromium Single Cell Human BCR Amplification Kit, and related items. The contract was set aside for small...
This firm fixed price purchase order contract was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services' National Institutes of Health (NIH), to 10X Genomics, Inc., a life sciences technology company specializing in single-cell and spatial analysis products and services. The contract, valued at $23,773.00, is for the procurement of 10X Chromium GEM-X Single Cell 3' Kits and GEM-X Single Cell 3' Chip Kits....
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $24,999.00 contract is for the delivery of 10X CHROMIUM NEXT GEM-X AND CHROMIUM SINGLE CELL HUMAN KITS, which are used for single-cell RNA sequencing and other single-cell analysis applications. 10X Genomics is a life sciences technology company that specializes in products and services...
This is a $81,062.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to 10X Genomics, Inc. for the supply of 10X Genomics Chromium X and Accessory Kits and a Chromium Next GEM Single Cell HT Training Kit. The award is set aside for small businesses. The products will support NIAID's biomedical research efforts, including work on neurological diseases and disorders. This award is part of...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to 10X Genomics, Inc. The $22,585.50 contract is for the delivery of 10X CHROMIUM GEM-X SINGLE CELL REAGENT KITS, with a performance period through September 30, 2024. The award has a small business set-aside designation. 10X Genomics is a life sciences technology company that specializes in products and services for...

This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to 10X Genomics, Inc., a small business manufacturer of life sciences technology products and services. The contract, valued at $23,501.50, is for the delivery of "CHROMIUM GEM REAGENT KITS" to support NIAID's biomedical research efforts. This contract appears to be part of a larger indefinite delivery contract that 10X Genomics holds with the NIH's National Institute of Neurological Disorders and Stroke, valued at up to $750,000, to provide optimization slides, reagent kits, and reagent delivery methods. The current contract has a completion date of June 30, 2025 and was awarded on August 26, 2024.

Generated 8/24/24, 9:06 AM